Skip to content
Subscriber Only

Oxford Starts First Study to Reinfect Recovered Covid Patients

  • Researchers seek 64 healthy, previously infected volunteers
  • Challenge trials hold advantages for studying viral activity
Video player cover image
Oxford Begins Trial to Reinfect Recovered Covid-19 Patients

We're tracking the latest on the coronavirus outbreak and the global response. Sign up here for our daily newsletter on what you need to know.

People who have fought off the Covid-19 virus will be deliberately reinfected in a first-of-its-kind trial at the University of Oxford that may shed light on how to develop more effective vaccines against the pathogen.